CT New Haven의 유방암 임상 시험
유방암 관련 연구 37개가 New Haven 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
피험자 모집 중1/2상
- Yale Cancer Center, New Haven
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
피험자 모집 중2상
- Yale Cancer Center, New Haven
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
피험자 모집 중1/2상
- Yale University School of Medicine - Yale Cancer Center, New Haven
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
피험자 모집 중1/2상
- Yale University School of Medicine, New Haven
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
피험자 모집 중1상
- Yale University - Yale University School of Medicine, New Haven
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
피험자 모집 중1상
- Yale Cancer Center, New Haven
Study of AVZO-021 in Patients With Advanced Solid Tumors
피험자 모집 중1/2상
- Avenzo Therapeutics Recruiting Site, New Haven
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
피험자 모집 중1상
- Yale Cancer Center, New Haven
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
피험자 모집 중3상
- Yale Cancer Center ( Site 0060), New Haven
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
피험자 모집 중3상
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale University/Yale Cancer Center/Yale School of Medicine, New Haven
- Smilow Cancer Hospital Care Center - North Haven, North Haven · 7마일 거리
- 외 2개
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
피험자 모집 중3상
- Research Site, New Haven
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
피험자 모집 중3상
- Clinical Trial Site, New Haven
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
피험자 모집 중
- Yale Cancer Center, New Haven
A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer
피험자 모집 중1상
- Yale University School Of Medicine, New Haven
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
피험자 모집 중2상
- Yale Cancer Center Clinical Trials Office, New Haven
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
피험자 모집 중3상
- Yale New Haven Hospital- Yale Cancer Center, New Haven
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
피험자 모집 중1/2상
- Yale Cancer Center, New Haven
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
피험자 모집 중3상
- Yale-New Haven Hospital-Yale Cancer Center, New Haven
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
피험자 모집 중3상
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7마일 거리
- Smilow Cancer Hospital-Derby Care Center, Derby · 8마일 거리
- 외 1개
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
피험자 모집 중3상
- Smilow Cancer Hospital at Yale New Haven, New Haven
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
피험자 모집 중1상
- Yale Cancer Center, New Haven
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
피험자 모집 중2상
- Yale University Cancer Center, New Haven
Optimizing Surgical Decisions in Young Adults With Breast Cancer
피험자 모집 중
- Yale Cancer Center, New Haven
ATEMPT 2.0: Adjuvant T-DM1 vs TH
피험자 모집 중2상
- Yale Cancer Center at Yale University School of Medicine, New Haven
- Smilow Cancer Hospital Care center at North Haven, North Haven · 7마일 거리
- Smilow Cancer Hospital Care center at Derby, Derby · 8마일 거리
- 외 1개
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
피험자 모집 중3상
- Yale Cancer Center - Smilow Cancer Hospital, New Haven
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
피험자 모집 중3상
- Yale University, New Haven
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- Yale University, Yale Cancer Center, New Haven
Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy
피험자 모집 중1상
- Yale Cancer Center Smilow Cancer Hospital, New Haven
Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns
피험자 모집 중관찰 연구
- Yale Cancer Center, New Haven
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
피험자 모집 중3상
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Smilow Cancer Hospital - North Haven, North Haven · 7마일 거리
- Smilow Cancer Hospital - Derby, Derby · 8마일 거리
- 외 1개
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
피험자 모집 중2상
- Yale Cancer Center, New Haven
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
피험자 모집 중3상
- Yale-New Haven Hospital Saint Raphael Campus, New Haven
- Yale University, New Haven
- Smilow Cancer Hospital-Orange Care Center, Orange · 5마일 거리
- 외 4개
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
피험자 모집 중1/2상
- Yale University, Yale Cancer Center, New Haven
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
피험자 모집 중
- Yale University, New Haven
DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY
피험자 모집 중2상
- Yale University, New Haven
The Cancer of the Pancreas Screening-5 CAPS5)Study
피험자 모집 중3상
- Yale University, New Haven
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
피험자 모집 중1상
- Yale University, New Haven
다른 도시의 유방암 시험
- New York City, NY연구 134개
- Houston, TX연구 126개
- Boston, MA연구 111개
- Nashville, TN연구 80개
- Los Angeles, CA연구 72개
- Edison, NJ연구 68개
- St. Louis, MO연구 64개
- Durham, NC연구 63개
- Queens, NY연구 63개
- Chicago, IL연구 58개
- Philadelphia, PA연구 56개
- Dallas, TX연구 55개
New Haven의 다른 연구
- 비소세포폐암연구 41개
- 암 (전체)연구 33개
- 전이성 암연구 23개
- 폐암연구 22개
- 두경부 편평세포암연구 22개
- 난소암연구 21개
- 대장직장암연구 20개
- 전립선암연구 20개
- 오피오이드 과다 복용연구 18개
- 알코올 사용 장애(AUD)연구 17개
- 급성 골수성 백혈병연구 17개
- 췌장암연구 16개
ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.